Accelerate Diagnostics Inc

NASDAQ:AXDX   4:00:00 PM EDT
0.87
+0.01 (+0.86%)
5:55:32 PM EDT: $0.87 0.00 (0.00%)
Earnings Announcements

Accelerate Diagnostics Reports Third Quarter 2022 Financial Results

Published: 11/14/2022 21:47 GMT
Accelerate Diagnostics Inc (AXDX) - Accelerate Diagnostics Reports Third Quarter 2022 Financial Results.
Accelerate Diagnostics Inc Q3 Sales Fell 3 Percent to $3.0 Million.
Accelerate Diagnostics Inc- Qtrly Loss per Share $0.18.
Revenue is expected to be $2.85 Million
Adjusted EPS is expected to be -$0.15

Next Quarter Revenue Guidance is expected to be $3.7 Million
Next Quarter EPS Guidance is expected to be -$0.13

More details on our Analysts Page.